Navigation Links
PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS, the 2nd Largest Drug Chain in the United States
Date:1/25/2012

SCHOFIELD, Wis., Jan. 25, 2012 /PRNewswire/ -- PuraMed BioScience, Inc. (OTCBB: PMBS) announced today that LipiGesic M, their clinically proven effective and safe, all natural product for the treatment of migraine headaches, is now available for purchase at CVS, the 2nd Largest Drug Chain in the United States. With the addition of over 7,000 CVS locations, LipiGesic®M is now available in approximately 15,000 stores nationwide.

"We are pleased to now have our LipiGesic®M product available in both the #1 and #2 Drug Chain stores in the United States.  Between the nearly 8,000 Walgreens and 7,000 CVS locations nationwide, we believe our product is gaining the exposure needed to generate significant revenue," stated Russ Mitchell, CEO of PuraMed BioScience.

PuraMed BioScience, Inc. anticipates announcing additional distribution in chain drug stores in the near future.

About PuraMed BioScience, Inc.:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products.  PuraMed has completed a double blind placebo clinical trial for its leading product, LipiGesic®M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. Please see the following link to view the abstract of that study.  http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract.  LipiGesic®M has national distribution and is available nationwide in some of the largest chain drug stores in the United States.  In addition to LipiGesic®M, the Company also has plans to launch LipiGesic®H for tension-type headaches as well as LipiGesic®PM which provides a remedy for insomnia and other sleep disorders.

For more information on PuraMed, visit the Company website at
'/>"/>

SOURCE PuraMed BioScience, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PuraMed BioScience, Inc. Has Its Lead Product, LipiGesic®M Featured in Flaherty Financial News
2. Crown Bioscience, Inc. Announces Closing of Series C Financing
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
4. Integware Announces Systems Integrator Agreement With Siemens PLM Software
5. Millennium Research Institute Announces 2012 Educational Initiatives
6. Tris Pharma Announces Appointment of Dr. Mahdi Fawzi as Top R&D Executive
7. Jazz Pharmaceuticals plc Announces New Executive Appointments
8. BD Announces Webcast of Annual Meeting of Shareholders
9. Codexis Announces CFO Departure
10. Elanco Animal Health Announces Lillys Agreement to Acquire ChemGen Corp.
11. Span-America Announces First Quarter Conference Call on the Internet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... BOTHELL, Wash. and VANCOUVER, British ... Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that ... SYNERGY trial showed a benefit with custirsen therapy in ... a poor prognosis. The analysis, exploring the effect of ... showed that over 40 percent of men in the ...
(Date:5/30/2015)... Caris Life Sciences®, a leading biotechnology ... medicine, today announced the presentation of data from ... Molecular Intelligence®, the company,s panomic comprehensive tumor profiling ... histological features. In separate presentations at the annual ... (ASCO) in Chicago, Ill. , ...
(Date:5/29/2015)... May 29, 2015  Today, UL LLC, a ... global provider of electronic quality management systems (EQMS) ... which will leverage the strengths of both organizations ... system implementation and comprehensive advice and guidance for ... EQMS capabilities to UL,s strength in regulatory services ...
Breaking Medicine Technology:OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 2OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 3OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 4OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 5OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis 6Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 2UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 3
... Jan. 14 Osteotech, Inc. (Nasdaq: OSTE ), a ... today reported preliminary unaudited revenue for the fourth quarter of 2009 ... for the same period in 2008.  During the fourth quarter, the ... its new innovative products all currently in limited launch phases.  Revenue ...
... , BEDFORD, Ohio , ... Ben Venue Laboratories, Inc., is pleased to announce FDA approval ... its existing Fluconazole Injection line. This product is AP rated ... an antifungal agent indicated for oropharyngeal and esophageal candidiasis, cryptococcal ...
Cached Medicine Technology:Osteotech Announces Preliminary Fourth Quarter 2009 Revenue 2Osteotech Announces Preliminary Fourth Quarter 2009 Revenue 3Osteotech Announces Preliminary Fourth Quarter 2009 Revenue 4Bedford Laboratories(TM) To Begin Shipping Fluconazole Injection 2Bedford Laboratories(TM) To Begin Shipping Fluconazole Injection 3Bedford Laboratories(TM) To Begin Shipping Fluconazole Injection 4
(Date:5/30/2015)... ProIntro Magnify contains 30 self-animating and minimalistic Titles including ... elegant opening title to any Final Cut Pro X ... layouts. ProIntro Magnify is created exclusively for Final Cut Pro ... Simply drag a preset into the FCPX timeline ... Inspector window then watch as ProIntro Magnify does the rest. ...
(Date:5/30/2015)... Angeles, CA (PRWEB) May 30, 2015 ... Caregiver Services in coordination with ONEgeneration Senior Enrichment Center, ... Area Manager Raymond de Guzman and Brain Fitness Program ... who joined this event learned that there are many ... Director Tee Bar showed the residents the different ways ...
(Date:5/30/2015)... 30, 2015 The iconic American actor, ... be hosting a new segment on Medical Malpractice. This ... medical malpractice in the health care field. , According ... of medical malpractice suits were filed, roughly only 20% ... settled out of court, while the remaining 30% were ...
(Date:5/30/2015)... New York, NY (PRWEB) May 30, 2015 ... on Wednesday, May 26th 2015, announcing that, “criminals used ... access to information on approximately 100,000 tax accounts through ... information, date of birth and street address.” , ... security industry to have to think it was only ...
(Date:5/29/2015)... CO (PRWEB) May 29, 2015 What ... from The Denver Foundation, community comes together to plant ... to build neighborhoods and awareness of critical issues. Community ... Metro Denver and beyond. , "What Community Does" was ... community foundation in Colorado, and released during the foundation’s ...
Breaking Medicine News(10 mins):Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 2Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5Health News:What Community Does: A New Video from The Denver Foundation 2
... the only treatment for a deteriorated hip joint. Now a ... replacements.// ,Bobby Castor plays on his school’s golf team. ... condition called avascular necrosis. Decreased blood flow caused his hip ... it hurt Castor’s game. “I was just limping around the ...
... People in the United States have steadily increased their ... person // in 1966 to 81 pounds per person ... significant higher levels of arsenic than other poultry or ... farmers use to control intestinal parasites in chickens. ...
... that strongly activates certain systems in the brain.// The ... often addictive. According to the 2000 National Household Survey ... United States have tried methamphetamine at least once in ... users and 18 healthy people to determine how brain ...
... that infects and destroys T-cells in the immune system. ... there are between 800,000 and 900,000 people living with ... less likely to be infected with HIV, and a ... from nine specimens of human foreskin. They found each ...
... people at increased risk for HIV and other infectious ... ,Shyness has been linked to infectious disease for ... noted people with a "melancholic temperament" were more likely ... that theory, showing introverts are more susceptible to upper ...
... SARS case in six months may have the coronavirus ... it was waiting for more results to come in.// ... may have contracted the SARS coronavirus," Xu Ruiheng, deputy ... control, said on Hong Kong cable television, citing results ...
Cached Medicine News:
... comfortable eye protection Properly manufactured radiation ... scatter radiation. Our high quality frames and ... with minimized weight. Our lenses are made ... meet all industry standards. Most Pulse Glasses ...
... and comfortable eye protection Properly manufactured ... of scatter radiation. Our high quality frames ... comfort with minimized weight. Our lenses are ... that meet all industry standards. Most Pulse ...
... lenses and frames are designed with the safety ... lenses are Schott RS-520 (also called SF-6) leaded ... These lenses meet standards, as set for optical ... ,While our eyewear is protecting your eyes, ...
Panoramic styling that contours closely to the face and brow. Saddle bridge fits average to fuller noses. Adjustable temple hinge adjusts up or down, longer or shorter. Soft cushion behind ear for co...
Medicine Products: